NCT01014273已完成3 期
An International Randomized Trial of Trans-radial Versus Trans-femoral PCI Access Site Approach in Patients With Unstable Angina or Myocardial Infarction Managed With an Invasive Strategy. An Extension to the CURRENT (OASIS 7) Substudy (EFC5695): Effect of Type of Access for PCI (Radial or Femoral) on Bleeding Rate-Substudy.
适应症
干预措施
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 7,021
- 试验地点
- 1
- 主要终点
- First occurrence of the composite of death, MI, stroke or non CABG major bleeding (i.e. severe bleeding, other major bleeding) at 30 days.
研究概览
简要总结
This is a multi-national, multi-centre, randomized study comparing the trans-radial PCI access strategy and the trans-femoral PCI access strategy in ACS patients with UA or NSTEMI or STEMI planned to be treated with an invasive strategy (PCI).
The hypothesis is that radial access site PCI will be associated with significantly less major bleeding and access site complications compared with a femoral approach, without increasing the risk of ischemic events. The overall benefit-risk profile will favor a trans-radial approach.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •1.1 UA/NSTEMI patients
- •Ischemic symptoms suspected to represent a non-ST segment elevation ACS (unstable angina [UA] or non-ST segment elevation myocardial infarction NSTEMI) defined as:
- •Clinical history consistent with new onset, or a worsening pattern, of characteristic ischemic chest pain occurring at rest or with minimal exercise (lasting longer than 10 minutes) and planned to be managed with an invasive strategy
- •AND at least one of the following:
- •Electrocardiogram (ECG) changes compatible with new ischemia [ST depression of at least 1mm or transient ST elevation or ST elevation of less than or equal to 1 mm or T wave inversion greater than 2 mm in at least 2 contiguous leads].
- •Patients > 60 years of age with normal ECG are eligible provided there is a high degree of certainty that presenting symptoms are due to myocardial ischemia. Such patients must have documented evidence of previous coronary artery disease (CAD) with at least one of the following:
- •Prior MI requiring hospitalization
- •Prior revascularization procedure (more than 3 months ago)
- •Cardiac catheterization showing significant CAD
- •Positive exercise test
- •Other objective evidence of atherosclerotic vascular disease or
- •Already elevated cardiac enzymes or troponin I or T above the upper limit of normal.
- •1.2 STEMI patients
- •Presenting with signs or symptoms of acute myocardial infarction lasting at least 20 minutes and planned to be managed with an invasive strategy with intent to perform a percutaneous coronary intervention (PCI) during the index hospitalization.
- •Definite ECG changes compatible with STEMI: persistent ST-elevation (> 2 mm in two contiguous precordial leads or > 1 mm in at least two limb leads), or new left bundle branch block, or Q-wave in 2 contiguous leads
- •Randomized during index hospitalization for acute coronary syndrome 3) Suitable candidate for either radial or femoral artery PCI 4) Intent to perform same-sitting angiography and PCI. 5) Palpable radial artery with documented normal Allen's test 6) Acceptance by operator to use whichever route is assigned by the randomization process 7) Previous experience of the operator with at least 50 cases of radial artery access within the past year 8) Written informed consent
排除标准
- •Age < 18 years
- •Active bleeding or significant increased risk of bleeding, severe hepatic insufficiency, current peptic ulceration, proliferative diabetic retinopathy.
- •Uncontrolled hypertension
- •Cardiogenic shock
- •Prior CABG surgery with use of more than one internal mammary artery
- •Documented severe peripheral vascular disease precluding a femoral approach
- •Participation in any study with an investigational drug or device within the previous 30 days
- •Medical, geographic or social factors making study participation impractical
研究组 & 干预措施
Trans-femoral access
Active Comparator
Femoral artery PCI access site
干预措施: Percutaneous Coronary Intervention (Procedure)
Trans-radial access
Active Comparator
Radial artery PCI access site
干预措施: Percutaneous Coronary Intervention (Procedure)
结局指标
主要结局
First occurrence of the composite of death, MI, stroke or non CABG major bleeding (i.e. severe bleeding, other major bleeding) at 30 days.
时间窗: 30 days
次要结局
- Non CABG major bleeding(within 30 days following randomization)
- Death, MI or stroke(within 30 days following randomization)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Beyond 12 Hours Reperfusion AlternatiVe Evaluation TrialMyocardial InfarctionNCT00759629Deutsches Herzzentrum Muenchen365
已完成
3 期
Clinical Trial of BCD-148 and Soliris® for the Treatment of Patients With Paroxysmal Nocturnal HemoglobinuriaParoxysmal Nocturnal HemoglobinuriaNCT04060264Biocad28
撤回
2 期
An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANYModerate and Severe COVID-19SARS-CoV-2 InfectionCOVID-19NCT04575064Professor Dr. Bernd Mühlbauer400
已完成
不适用
Clinical Trial Comparing C-Brace to Knee Ankle Foot Orthosis (KAFO)/Stance Control Orthosis (SCO)Pareses, Lower ExtremityNCT03906656Otto Bock Healthcare Products GmbH149
已完成
4 期
Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 DiabetesDiabetes Mellitus, Type 2DiabetesNCT00469092Novo Nordisk A/S480